Physician

Shehzadi Ghazala Nagra, MD

According to 2025 Medicare claims, Shehzadi Nagra, MD (NPI: 1356579569) practices infectious disease in the Wichita Falls, TX market, with the plurality of this provider's patient population coming from Wichita, TX. This provider's primary affiliated billing organization is SHEHZADI NAGRA MD PLLC (NPI: 1245666759; TIN: 463612896) and primary practice location at 76301-5619. Nagra is affiliated with the Lifecare ACO LLC (ACO ID: A3644), Caravan Health ACO 43 LLC (ACO ID: A4974), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Nagra's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 559 traditional Medicare patients, billed 701,447 HCPCS/CPT codes, and received $1,095,556 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 2,443 prescription claims across 373 beneficiaries totaling $1,196,579 in drug costs, led by Biktarvy (Bictegrav/Emtricit/Tenofov Ala). DME data shows 13 claims. Open Payments data shows 24 records totaling $467. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $128,063 to $1,095,556. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $384,609 to $1,196,579. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$690K$1.4M2015 Medicare payment: $128,063 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $150,675 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $120,694 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $163,700 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $225,534 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $475,280 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $783,521 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,324,500 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,380,447 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,095,556 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201540149,240$128,063
201635313,338$150,675
201733545,923$120,694
201827628,506$163,700
201940314,350$225,534
202034665,750$475,280
2021425343,082$783,521
20224611,105,665$1,324,500
2023542882,886$1,380,447
2024559701,447$1,095,556

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$905K$1.8M2015 Drug cost: $384,609 (USD; Tot_Drug_Cst)2016 Drug cost: $291,828 (USD; Tot_Drug_Cst)2017 Drug cost: $201,380 (USD; Tot_Drug_Cst)2018 Drug cost: $158,886 (USD; Tot_Drug_Cst)2019 Drug cost: $353,950 (USD; Tot_Drug_Cst)2020 Drug cost: $1,688,207 (USD; Tot_Drug_Cst)2021 Drug cost: $1,810,696 (USD; Tot_Drug_Cst)2022 Drug cost: $1,697,968 (USD; Tot_Drug_Cst)2023 Drug cost: $1,583,263 (USD; Tot_Drug_Cst)2024 Drug cost: $1,196,579 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015124597$384,609
2016128571$291,828
2017122585$201,380
2018149620$158,886
2019209960$353,950
20202601,629$1,688,207
20213102,244$1,810,696
20223182,093$1,697,968
20233562,190$1,583,263
20243732,443$1,196,579

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$20K$40K2023 Medicare payment: $39,856 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $40,139 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/R13$39,856
2024N/R13$40,139

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes273319$126
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more6969$124
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more352646$91
96365Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less1142,621$46
J1335Injection, ertapenem sodium, 500 mg562,967$9

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
BiktarvyBictegrav/Emtricit/Tenofov Ala1183,540$477,162
DaptomycinDaptomycin1611,099$98,147
DovatoDolutegravir Sodium/Lamivudine26780$78,799
OdefseyEmtricitab/Rilpiviri/Tenof Ala20600$70,210
GenvoyaElviteg/Cob/Emtri/Tenof Alafen17510$67,253

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J1561Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mgNN/R13$40,139

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.24$467ViiV Healthcare Company
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Shehzadi Ghazala Nagra, MD?

Tedicare shows public-source Medicare data for Shehzadi Ghazala Nagra, MD (NPI 1356579569), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shehzadi Ghazala Nagra, MD have ACO affiliation data?

Shehzadi Ghazala Nagra, MD is shown with ACO affiliation data for Lifecare ACO LLC (MSSP, ACO ID A3644), Caravan Health ACO 43 LLC (MSSP, ACO ID A4974), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Shehzadi Ghazala Nagra, MD?

Shehzadi Ghazala Nagra, MD is linked to SHEHZADI NAGRA MD PLLC (billing NPI 1245666759) in the available physician profile data.

Does Shehzadi Ghazala Nagra, MD have Open Payments data?

Shehzadi Ghazala Nagra, MD has 24 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.